[Our experience in the treatment of acute lymphoblastic leukemias (ALL) having different risk levels with the BFM-83 therapeutic protocol]
An Esp Pediatr
.
1988 Oct:29 Suppl 34:68-72.
[Article in Spanish]
Authors
M Bernacer
1
,
J Aracil
,
T Contra
,
C Gil
,
J López
,
B López-Ibor
,
N Martín
,
C Melero
,
F Valverde
,
C Vecilla
Affiliation
1
Fundación Jiménez Díaz, Servicio de Pediatría, Madrid.
PMID:
3214042
No abstract available
MeSH terms
Antineoplastic Agents / therapeutic use*
Child
Child, Preschool
Clinical Protocols
Female
Humans
Infant
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Risk Factors
Substances
Antineoplastic Agents